RSPO2 and in situ carcinoma: FGF19 is the human orthologue to mouse gene, Fgf15. Eleven of the CIS genes (Table 7) were ranked as high-risk genes in cancer and 3 of these genes (PDGFRA, RSPO2, and WNT10B) were mutated in human tumors.